학술논문
Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the CLARICOR randomised, blinded clinical trial
Document Type
Article
Author
Source
In International Journal of Cardiology 1 March 2015 182:459-465
Subject
Language
ISSN
0167-5273